P1575: TIKSAGEVIMAB/TSILGAVIMAB: EXPERIENCE OF USE FOR PRE-EXPOSURE PROPHYLAXIS OF COVID-19 IN ADULT PATIENTS WITH ONCOHEMATOLOGICAL DISEASES

P1575: TIKSAGEVIMAB/TSILGAVIMAB: EXPERIENCE OF USE FOR PRE-EXPOSURE PROPHYLAXIS OF COVID-19 IN ADULT PATIENTS WITH ONCOHEMATOLOGICAL DISEASES

Bibliographic Details
Main Authors:	Daria Chebykina, Sergey Voloshin, Marina Zenina, Alexey Kuvshinov
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000973176.14316.1a

Similar Items

PB2060: THE RESULTS OF A FOUR YEARS LONG OBSERVATION OF APLASTIC AMENIA PATIENTS DEPENDING ON A PROGRAM OF IMMUNOSUPPRESSIVE THERAPY
by: Daria Chebykina, et al.
Published: (2023-08-01)

HIV: Pre-exposure prophylaxis
by: Ajai Kumar Singh, et al.
Published: (2012-01-01)

Use of biological microarrays in oncohematology
by: T. V. Nasedkina
Published: (2022-11-01)

Oncohematologic diseases and rheumatic disorders
by: Nelson Hamerschlak
Published: (2008-03-01)

Pre-exposure Prophylaxis: The Delivery Challenge
by: Willem D. F. Venter
Published: (2018-07-01)

HIV pre-exposure prophylaxis for women
by: Anandi N. Sheth, et al.
Published: (2016-07-01)

Observation of oncohematologic patients by general pediatricians
by: S. R. Varfolomeyeva, et al.
Published: (2022-11-01)

INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS
by: O. V. Shadrivova, et al.
Published: (2018-07-01)

Characteristics of HCV infection in oncohematological patients
by: D. A. Lioznov, et al.
Published: (2020-03-01)

Biosensors in Clinical Practice: Focus on Oncohematology
by: Agostino Cortelezzi, et al.
Published: (2013-05-01)

Identification of platelet refractoriness in oncohematologic patients
by: Aline Aparecida Ferreira, et al.
Published: (2011-01-01)

CHARACTERISTIC OF CATHETERS AND OF CHILDREN WITH ONCOHEMATOLOGICAL DISEASE
by: Liziane Barros Linares Machado, et al.
Published: (2017-03-01)

Missions and potentialities of municipal oncohematological service
by: V V Ptushkin
Published: (2016-12-01)

Comparing Self-Report Pre-Exposure Prophylaxis Adherence Questions to Pharmacologic Measures of Recent and Cumulative Pre-Exposure Prophylaxis Exposure
by: Jill Blumenthal, et al.
Published: (2019-07-01)

Pre-exposure and Post-exposure prophylaxis for dog bites
by: Beuy Joob, et al.
Published: (2017-01-01)

Awareness and willingness to use pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) among sexually active adults in Ghana
by: Samuel Nuamah Eshun, et al.
Published: (2023-11-01)

PRE-EXPOSURE PROPHYLAXIS FOR PREVENTION OF HIV INFECTION
by: Ana Rita Diniz, et al.
Published: (2015-04-01)

Towards Understanding the Pathogenicity of DROSHA Mutations in Oncohematology
by: Dmitrii S. Bug, et al.
Published: (2021-09-01)

Prevention and treatment of thrombosis in cancer and oncohematological patients
by: O. V. Somonova, et al.
Published: (2021-11-01)

MUCORMYCOSIS IN ONCOHEMATOLOGY PATIENTS (results of the prospective study)
by: N. N. Klimko, et al.
Published: (2017-06-01)

Trends in the treatment of cytomegalovirus infection in oncohematological patients
by: D. N. Balashov
Published: (2014-07-01)

COMBINATION OF INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS
by: O. V. Shadrivova, et al.
Published: (2018-02-01)

Microarrays: a new era in development of oncohematology
by: Ye. A. Nikitin, et al.
Published: (2022-11-01)

Trends in the treatment of cytomegalovirus infection in oncohematological patients
by: D. N. Balashov
Published: (2014-07-01)

Reduction of emotional distress in patients with oncohematologic diseases
by: Yudisbel Rodríguez Rodríguez, et al.
Published: (2011-01-01)

Bioethical aspects of palliative care to patient oncohematologic
by: Olga Lidia Alonso Mariño, et al.
Published: (2015-03-01)

HOSPITALIZATION ONCOHEMATOLOGICAL CLIENT SUBSIDIES FOR NURSING CARE
by: Renata Miranda Sousa, et al.
Published: (2012-08-01)

HOSPITALIZATION ONCOHEMATOLOGICAL CLIENT SUBSIDIES FOR NURSING CARE
by: Renata Miranda Sousa, et al.
Published: (2012-08-01)

Accompanying therapy in oncohematological patients with secondary immunodeficiency
by: Lali G. Babicheva, et al.
Published: (2020-07-01)

Pre-exposure prophylaxis (PrEP) means more exposure?
by: Andrea Menezes Gonçalves
Published: (2018-07-01)

Exploring Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Knowledge in Incarcerated Men
by: Pamela Valera, et al.
Published: (2022-07-01)

Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies
by: Anna A. Roppelt, et al.
Published: (2023-02-01)

An interdisciplinary approach to the management of oncohematological patients with immunodeficiency: clinical cases. A review
by: Lali G. Babicheva, et al.
Published: (2023-12-01)

Fray Alberto arquitecto (1575 – 1635)
by: Carlos J. Irisarri
Published: (2023-12-01)

Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi
by: Giulia Zamprogna, et al.
Published: (2023-05-01)

Pre-exposure Prophylaxis Against Human Immunodeficiency Virus
by: Güle ÇINAR, et al.
Published: (2018-03-01)

Flattening the Risk: Pre-Exposure Prophylaxis for COVID-19
by: Stricker RB, et al.
Published: (2020-10-01)

The implementation of pre-exposure prophylaxis in Spain without women
by: Iván Martínez Fernández
Published: (2018-06-01)

Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women
by: Fesler MC, et al.
Published: (2021-01-01)

Visualization of Truvada as pre-exposure prophylaxis in HIV infection
by: Won-Bin Young, et al.
Published: (2016-05-01)